Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter: Part 3. A potential 5-HT transporter imaging agent, 3-(3-[18F]Fluoropropyl)-6-nitroquipazine
- Authors
- Lee B.S.; Chu S.; Lee K.C.; Lee B.-S.; Chi D.Y.; Choe Y.S.; Kim S.E.; Song Y.S.; Jin C.
- Issue Date
- Nov-2003
- Publisher
- Pergamon Press Ltd.
- Citation
- Bioorganic and Medicinal Chemistry, v.11, no.23, pp 4949 - 4958
- Pages
- 10
- Journal Title
- Bioorganic and Medicinal Chemistry
- Volume
- 11
- Number
- 23
- Start Page
- 4949
- End Page
- 4958
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/149072
- DOI
- 10.1016/j.bmc.2003.09.009
- ISSN
- 0968-0896
1464-3391
- Abstract
- 3-(3-[F-18]Fluoropropyl)-6-nitroquipazine ([F-18]FPNQ) as a 5-HT transporter imaging agents was designed, synthesized, and evaluated. FPNQ was selected due to its potent in vitro biological activity (K-i = 0.32 nM) in rat brain cortical membranes. The F-18-labeled FPNQ was prepared by reaction of the propyl mesylate as a precursor with tetra-n-butylammonium [F-18]fluoride generated under NCA conditions. The precursor mesylate was synthesized from commercially available hydrocarbostyril in nine steps in 21% overall yield. The specific activity of the [F-18]FPNQ determined by radioreceptor assay was 27.0 GBq/mumol. Tissue distribution studies in mice showed the highest uptake in the frontal cortex (5.79 %ID/g) at 60 min post-injection. (C) 2003 Elsevier Ltd. All rights reserved.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.